Yunxiang Zhou

11PUBLICATIONS
11CO-AUTHORS
Microbial ecologyPredictive and prognostic markersMolecular targetsEpigenetics (incl. genome methylation and epigenomics)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 28, 2026
The role of human microbiota in breast cancer pathogenesis and treatment.

|Aug 24, 2026
Timing and Patterns of Relapse-Related Events Following Adjuvant CDK4/6 Inhibitors Combined With Endocrine Therapy in Patients With HR-Positive, HER2-Negative Early Breast Cancer.

|Mar 20, 2026
Recent Advances in Antibody-Drug Conjugates and Immunotherapy Combinations for Treatment of Triple-Negative Breast Cancer.

Huihui Chen, Wei Lu, Yunxiang Zhou

|Feb 02, 2026
A Highly Sensitive and High-Throughput Quantitative HILIC-MS/MS Method for Systematic Profiling of RNA Modifications.

Cheng Guo, Xiujuan Hong, Yiqiu Hu

|Oct 13, 2025
Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER).

Yunxiang Zhou, Zhiyun Zhang, Huihui Chen

|Sep 12, 2025
Investigation of Thrombocytopenia Associated with Trastuzumab Emtansine Treatment in Breast Cancer: A Retrospective Study in a Chinese Population.

Kun Zhang, Shijie Wu, Yunxiang Zhou

Pageof 2

Frequent Collaborators

3 joint publications

Yiding Chen

2 joint publications

Shijie Wu

1 joint publications

John H Zhang

1 joint publications

Anwen Shao